西亚试剂：Casein kinase 1α governs antigen-receptor-induced NF-B acti

发布时间：2026-02-26

Casein kinase 1α governs antigen-receptor-induced NF-B activation and human lymphoma cell survival

Nicolas Bidère1,4,6, Vu N. Ngo2,6, Jeansun Lee1, Cailin Collins2, Lixin Zheng1, Fengyi Wan1, R. Eric Davis2, Georg Lenz2, D. Eric Anderson3, Damien Arnoult4, Aimé Vazquez4, Keiko Sakai1,7, Jun Zhang1, Zhaojing Meng5, Timothy D. Veenstra5, Louis M. Staudt2,6 & Michael J. Lenardo1,6

1 Molecular Development Section, Laboratory of Immunology, National Institute of Allergy and Infectious Diseases
2 Metabolism Branch, Center for Cancer Research, National Cancer Institute,
3 Proteomics and Mass Spectrometry Facility, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
4 U542, INSERM, Université Paris-Sud, H?pital Paul Brousse, Villejuif 94800, France
5 Laboratory of Proteomics and Analytical Technologies (LPAT), National Cancer Institute, Frederick, Maryland 21702, USA
6 These authors contributed equally to this work.
7 Present address: Division of Viral Immunology, Center for AIDS Research, Kumamoto University, 2-2-1 Honjhou, Kumamoto-shi, Kumamoto-ken 860-0811, Japan.

The transcription factor NF-κB is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types1, 2. Antigen receptor stimulation assembles an NF-κB activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-κB kinase complex3, 4, 5, 6, 7, 8, 9, 10, 11, 12, but signal transduction is not fully understood1α. We conducted parallel screens involving a mass spectrometry analysis of CARMA1 binding partners and an RNA interference screen for growth inhibition of the CBM-dependent 'activated B-cell-like' (ABC) subtype of diffuse large B-cell lymphoma (DLBCL)12. Here we report that both screens identified casein kinase 1α (CK1α) as a bifunctional regulator of NF-κB. CK1α dynamically associates with the CBM complex on T-cell-receptor (TCR) engagement to participate in cytokine production and lymphocyte proliferation. However, CK1α kinase activity has a contrasting role by subsequently promoting the phosphorylation and inactivation of CARMA1. CK1α has thus a dual 'gating' function which first promotes and then terminates receptor-induced NF-κB. ABC DLBCL cells required CK1α for constitutive NF-κB activity, indicating that CK1α functions as a conditionally essential malignancy gene—a member of a new class of potential cancer therapeutic targets.

• 以上资料由西亚试剂：http://www.xiyashiji.com/ 提供此产品的详细信息如密度,含量,分子式,分子量等均可在西亚官网查询   
• 相关产品如汞乙酸汞氯化汞氧化汞碘化汞硫酸汞硝酸汞溴化汞硝酸亚汞氯化亚汞乙酸苯汞碘化汞钾硫氰酸汞氯化氨基汞三氯生三氯氧磷三氯乙烯水合氯醛三氯化磷三氯化钌三氯化钛三氯化铱三氯化铑三氯硫磷三氯乙烷三氯甲烷三氯卡班TCC1,3,5-三氯苯1,2,4-三氯苯1,2,3-三氯苯无水氯化铝三氯乙酸酐三氯乙酸钠碘甲烷二碘甲烷三碘甲烷 三氟碘甲烷硫酸二甲酯氯磺酸苯硫酚苯硫酚钠3-氨基苯硫酚2,6-二氯苯硫酚2,4-二氯苯硫酚2,5-二氯苯硫酚2-甲氧基苯硫酚2-氯乙醇 等均有销售.欢迎订购

 

上一篇：西亚试剂：DNA Methylation Mediated by a MicroRNA Pathway
下一篇：东京大学成功合成了一种以二氧化碳为原料的新型塑料